NASDAQ : MCRB
Seres Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.95 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 19.59M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Seres Therapeutics, Inc. (MCRB) reported revenue of 1.88M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.88M | 789.00K | 144.93M | |||
| Cost of Revenue | 47.96M | 55.60M | 68.13M | 117.60M | 109.65M | 141.89M |
| Gross Profit | -46.08M | -54.81M | -68.13M | -117.60M | -109.65M | 3.04M |
| Selling, General & Admin | 32.15M | 39.16M | 53.18M | 77.50M | 70.26M | 69.26M |
| Other Operating Expenses | -1.73M | |||||
| Operating Expenses | 32.15M | 39.16M | 53.18M | 77.50M | 70.26M | 67.53M |
| Operating Income | -78.23M | -93.97M | -121.31M | -195.10M | -179.91M | -64.49M |
| Interest Expense | -2.47M | -6.02M | -2.91M | |||
| Interest & Investment Income | 1.57M | 2.23M | 3.97M | 7.30M | 3.06M | 2.87M |
| Other Non Operating Income (Expenses) | 6.51M | 16.59M | 9.29M | -102.00K | -17.00K | -547.00K |
| EBT Excluding Unusual Items | -70.14M | -75.16M | -108.06M | -190.37M | -182.89M | -65.08M |
| Gain (Loss) on Sale of Investments | 236.00K | -688.00K | -498.00K | |||
| Gain (Loss) on Sale of Assets | 53.49M | 80.85M | 5.68M | |||
| Other Unusual Items | -23.40M | |||||
| Pretax Income | -22.46M | 5.70M | -125.77M | -190.13M | -183.58M | -65.58M |
| Earnings From Continuing Operations | -22.46M | 5.70M | -125.77M | -190.13M | -183.58M | -65.58M |
| Earnings From Discontinued Operations | 125.91M | 76.41M | -66.58M | |||
| Net Income | -22.46M | 5.70M | 136.00K | -113.72M | -250.16M | -65.58M |
| Net Income to Common | -22.46M | 5.70M | 136.00K | -113.72M | -250.16M | -65.58M |
| Shares Outstanding (Basic) | 9.32M | 8.86M | 7.77M | 6.40M | 5.40M | 4.59M |
| Shares Outstanding (Diluted) | 9.32M | 8.87M | 7.77M | 6.40M | 5.40M | 4.59M |
| EPS (Basic) | -2.41 | 0.64 | 0.02 | -17.77 | -46.29 | -14.30 |
| EPS (Diluted) | -2.41 | 0.64 | 0.00 | -17.77 | -46.29 | -14.30 |
| Free Cash Flow | -51.30M | 865.00K | -148.99M | -125.33M | -238.64M | -2.88M |
| Free Cash Flow Per Share | -5.50 | 0.10 | -19.18 | -19.58 | -44.16 | -0.63 |
| Gross Margin | 2.10% | |||||
| Operating Margin | -4,154.38% | -11,910.14% | -44.50% | |||
| Profit Margin | -1,192.94% | 721.93% | -45.25% | |||
| Free Cash Flow Margin | -2,724.11% | 109.63% | -1.99% | |||
| EBITDA | -74.78M | -89.84M | -115.85M | -188.85M | -173.28M | -58.55M |
| EBITDA Margin | -40.40% | |||||
| D&A For EBITDA | 3.45M | 4.13M | 5.47M | 6.24M | 6.63M | 5.95M |
| EBIT | -78.23M | -93.97M | -121.31M | -195.10M | -179.91M | -64.49M |
| EBIT Margin | -44.50% | |||||
| Revenue as Reported | 1.88M | 789.00K | 144.93M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 15.59M | 45.77M | 30.79M | 127.97M | 163.03M | 180.00M |
| Short-Term Investments | 18.31M | 110.70M | ||||
| Cash & Short-Term Investments | 15.59M | 45.77M | 30.79M | 127.97M | 181.34M | 290.71M |
| Receivables | 25.27M | 517.00K | 4.75M | |||
| Prepaid Expenses | 1.48M | 3.09M | 3.13M | 8.05M | 13.42M | 12.92M |
| Other Current Assets | 39.40M | |||||
| Total Current Assets | 42.35M | 49.38M | 38.67M | 175.41M | 194.76M | 303.63M |
| Property, Plant & Equipment | 56.97M | 80.12M | 92.44M | 108.03M | 133.97M | 36.15M |
| Long-Term Investments | 495.00K | |||||
| Other Long-Term Assets | 2.27M | 8.70M | 8.70M | 75.16M | 20.05M | 14.59M |
| Total Assets | 101.59M | 138.19M | 139.81M | 358.60M | 348.78M | 354.86M |
| Accounts Payable | 1.19M | 1.68M | 4.08M | 3.64M | 17.44M | 13.73M |
| Accrued Expenses | 3.74M | 3.97M | 10.72M | 22.51M | 25.07M | 24.00M |
| Current Portion of Long-Term Debt | 456.00K | |||||
| Current Portion of Leases | 11.83M | 10.39M | 8.67M | 5.59M | 3.60M | 6.61M |
| Current Unearned Revenue | 4.26M | 16.82M | ||||
| Other Current Liabilities | 3.28M | 3.28M | 17.75M | 66.92M | 34.77M | 21.10M |
| Total Current Liabilities | 20.03M | 19.32M | 41.22M | 98.66M | 85.60M | 82.26M |
| Long-Term Debt | 101.54M | 50.59M | 24.64M | |||
| Long-Term Leases | 44.82M | 72.58M | 82.97M | 91.65M | 107.94M | 17.96M |
| Long-Term Unearned Revenue | 92.43M | 87.00M | ||||
| Other Long-Term Liabilities | 2.21M | 2.08M | 1.84M | 111.60M | 1.44M | 11.49M |
| Total Liabilities | 67.05M | 93.97M | 126.03M | 403.46M | 338.00M | 223.35M |
| Common Stock | 10.00K | 10.00K | 9.00K | 135.00K | 125.00K | 92.00K |
| Additional Paid-In Capital | 1.02B | 1.02B | 991.87M | 933.24M | 875.18M | 745.83M |
| Retained Earnings | -987.74M | -972.40M | -978.10M | -978.24M | -864.51M | -614.35M |
| Comprehensive Income & Other | -12.00K | -60.00K | ||||
| Shareholders' Equity | 34.53M | 44.22M | 13.78M | -44.86M | 10.78M | 131.51M |
| Total Liabilities & Equity | 101.59M | 138.19M | 139.81M | 358.60M | 348.78M | 354.86M |
| Total Debt | 56.64M | 82.97M | 91.64M | 198.78M | 162.59M | 49.21M |
| Net Cash (Debt) | -41.05M | -37.20M | -60.85M | -70.82M | 18.75M | 241.50M |
| Net Cash Per Share | -4.40 | -4.19 | -7.83 | -11.06 | 3.47 | 52.67 |
| Filing Date Shares Outstanding | 9.94M | 9.59M | 8.72M | 7.55M | 6.30M | 4.60M |
| Total Common Shares Outstanding | 9.83M | 9.56M | 8.65M | 6.75M | 6.26M | 4.59M |
| Working Capital | 22.32M | 30.05M | -2.55M | 76.75M | 109.17M | 221.37M |
| Book Value Per Share | 3.51 | 4.63 | 1.59 | -6.64 | 1.72 | 28.62 |
| Tangible Book Value | 34.53M | 44.22M | 13.78M | -44.86M | 10.78M | 131.51M |
| Tangible Book Value Per Share | 3.51 | 4.63 | 1.59 | -6.64 | 1.72 | 28.62 |
| Machinery | 29.62M | 32.43M | 32.91M | 33.09M | 31.58M | 23.61M |
| Construction In Progress | 861.00K | 861.00K | 861.00K | 1.11M | 3.97M | 1.67M |
| Leasehold Improvements | 30.61M | 30.95M | 30.95M | 32.49M | 32.47M | 32.92M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -22.46M | 5.70M | 136.00K | -113.72M | -250.16M | -65.58M |
| Depreciation & Amortization | 11.85M | 12.53M | 14.67M | 6.24M | 6.63M | 5.95M |
| Other Amortization | 1.41M | 1.14M | 705.00K | 2.53M | ||
| Loss (Gain) From Sale of Assets | -53.00K | -192.00K | -146.39M | |||
| Asset Writedown & Restructuring Costs | 5.81M | 3.27M | ||||
| Loss (Gain) From Sale of Investments | -236.00K | 688.00K | 498.00K | |||
| Stock-Based Compensation | 9.19M | 10.84M | 20.97M | 34.10M | 25.48M | 20.22M |
| Other Operating Activities | 114.00K | 20.00K | 22.84M | 14.10M | 6.23M | 1.54M |
| Change in Accounts Receivable | -24.39M | 1.55M | 6.61M | -8.67M | 9.39M | |
| Change in Inventory | -33.80M | -29.65M | ||||
| Change in Accounts Payable | -1.01M | -2.40M | -2.94M | -11.58M | 2.20M | 9.36M |
| Change in Unearned Revenue | -4.12M | 6.41M | -7.13M | -4.36M | ||
| Change in Other Net Operating Assets | -30.30M | -26.93M | -31.26M | -15.48M | -13.47M | 27.14M |
| Operating Cash Flow | -51.26M | 1.12M | -148.61M | -117.35M | -228.82M | 6.69M |
| Capital Expenditures | -37.00K | -252.00K | -380.00K | -7.97M | -9.82M | -9.57M |
| Sale of Property, Plant & Equipment | 224.00K | 210.00K | ||||
| Divestitures | 141.27M | |||||
| Investment in Securities | 18.56M | 92.25M | 73.65M | |||
| Other Investing Activities | 1.40M | |||||
| Investing Cash Flow | 187.00K | -42.00K | 142.29M | 10.58M | 82.43M | 64.09M |
| Long-Term Debt Issued | 103.38M | 27.61M | ||||
| Long-Term Debt Repaid | -127.91M | -52.86M | -1.91M | -948.00K | ||
| Net Debt Issued (Repaid) | -127.91M | 50.52M | 25.70M | -948.00K | ||
| Issuance of Common Stock | 14.86M | 13.90M | 37.53M | 21.19M | 103.90M | 2.13M |
| Financing Cash Flow | 14.86M | 13.90M | -90.37M | 71.70M | 129.60M | 1.18M |
| Foreign Exchange Rate Adjustments | -1.00K | 2.00K | -1.00K | -1.00K | ||
| Miscellaneous Cash Flow Adjustments | 1.00K | |||||
| Net Cash Flow | -36.21M | 14.97M | -96.69M | -35.06M | -16.79M | 71.95M |
| Free Cash Flow | -51.30M | 865.00K | -148.99M | -125.33M | -238.64M | -2.88M |
| Free Cash Flow Margin | -2,724.11% | 109.63% | -1.99% | |||
| Free Cash Flow Per Share | -5.50 | 0.10 | -19.18 | -19.58 | -44.16 | -0.63 |
| Levered Free Cash Flow | -64.60M | -54.96M | -60.11M | -112.46M | -87.82M | 14.04M |
| Unlevered Free Cash Flow | -64.60M | -54.96M | -61.52M | -112.06M | -84.77M | 13.34M |
| Cash Interest Paid | 10.86M | 12.55M | 4.93M | 2.45M | ||
| Change in Working Capital | -55.70M | -27.78M | -65.51M | -58.98M | -18.39M | 41.53M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 18.38M | 134.61M | 141.88M | 180.96M | 697.71M | 765.09M |
| Enterprise Value | 59.43M | 172.23M | 168.67M | 223.33M | 540.75M | 461.49M |
| Last Close Price | 1.83 | 14.88 | 16.62 | 28.00 | 112.00 | 166.60 |
| PE Ratio | 23.63 | 1,043.26 | ||||
| PS Ratio | 9.76 | 170.61 | 5.28 | |||
| PB Ratio | 0.52 | 3.04 | 10.29 | -4.03 | 64.70 | 5.82 |
| P/TBV Ratio | 0.53 | 3.04 | 10.29 | 64.70 | 5.82 | |
| P/FCF Ratio | 155.62 | |||||
| P/OCF Ratio | 120.51 | 114.40 | ||||
| EV/Sales Ratio | 31.56 | 218.28 | 3.18 | |||
| EV/FCF Ratio | 199.11 | |||||
| Debt / Equity Ratio | 1.64 | 1.88 | 6.65 | -4.43 | 15.08 | 0.37 |
| Debt / FCF Ratio | 95.91 | |||||
| Net Debt / Equity Ratio | 1.19 | 0.84 | 4.41 | -1.58 | -1.74 | -1.84 |
| Net Debt / EBITDA Ratio | -0.55 | -0.41 | -0.53 | -0.38 | 0.11 | 4.12 |
| Net Debt / FCF Ratio | -0.80 | 43.01 | -0.41 | -0.56 | 0.08 | 83.91 |
| Asset Turnover | 0.01 | 0.01 | 0.41 | |||
| Quick Ratio | 2.04 | 2.40 | 0.86 | 1.30 | 2.12 | 3.53 |
| Current Ratio | 2.11 | 2.56 | 0.94 | 1.78 | 2.27 | 3.69 |
| Return on Equity (ROE) | -66.57% | 19.64% | -258.04% | -42.83% | ||
| Return on Assets (ROA) | -39.85% | -42.25% | -30.43% | -34.48% | -31.96% | -11.55% |
| Return on Capital Employed (ROCE) | -95.90% | -79.10% | -123.10% | -75.10% | -68.40% | -23.70% |
| Earnings Yield | -131.82% | 4.23% | 0.10% | -62.84% | -35.85% | -8.57% |
| FCF Yield | -279.05% | 0.64% | -105.01% | -69.26% | -34.20% | -0.38% |
| Buyback Yield / Dilution | -10.79% | -14.16% | -21.40% | -18.44% | -17.86% | -14.93% |